SOUTHWEST ONCOLOGY GROUP

参与设计的多学科方法，并 开展恶性疾病的临床试验。这些疾病包括 成人实体瘤、淋巴瘤、多发性骨髓瘤、白血病等 肿瘤将由西南肿瘤学小组研究。 这些研究将被归类为第一阶段，以评估 新组合的毒性、耐受量和治疗范围 药物；第二阶段，以确定 用新的药物缓解；以及第三阶段建立亲属 肿瘤性疾病不同治疗方案的疗效比较。 为了研究生物化学和生物学方面的一些问题 正在研究的肿瘤，因为它们来自可用于治疗的患者材料 合作学习。 积极参与集团的整体工作并作出贡献。 这将包括科学投入、对协议设计的支持、 担任研究主席和所要求的行政任务。

To participate in the multidisciplinary approach to the design and conduct of clinical trials in malignant diseases. These diseases include adult solid tumors, lymphoma, multiple myeloma, leukemia, and other neoplasms to be studies by the Southwest Oncology Group. These studies will be classified as phase I for the evaluation of toxicity, tolerated dosage and therapeutic range of new combinations of agents; phase II to determine the frequency, extent and duration of remission with new agents; and phase III to establish the relative efficacy of various therapeutic regimens in neoplastic diseases. To investigate some of the biochemical and biological aspects of the neoplasms under study as they derive from patient material available for the cooperative studies. To actively participate in and contribute to the overall Group effort. This will include scientific input, support in protocol design, chairmanship of studies and requested administrative tasks.